Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Actinic Keratoses: full-pipeline trial registry
3 of 13 indexed Actinic Keratoses trials are currently recruiting.
Corpus placement: #1,315 of 28,707 conditions by registered trial count.
13 US clinical trials · 3 currently recruiting · #1,315 of 28,707 conditions by registered trial count
Actinic Keratoses: 13 US clinical trials tracked, 3 recruiting.
Actinic Keratoses is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Wright State University, running 2 of these trials.
Enrollment posture brief
Registry condition actinic-keratoses
OPEN 3 | RECR 23% | LATE 4 | EARLY 3 | RANK #1315 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Endometrial Serous Adenocarcinoma (23% recruiting · 13 trials)
Actinic Keratoses lists 3 open slots (23% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Actinic Keratoses on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Actinic Keratoses is recruiting below its size-band peers.
3 of 13 indexed trials (23.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Actinic Keratoses research.
Wright State University accounts for 2 of 13 trials (15.4%). 11 distinct sponsors appear on at least one study for this condition label.
-
Most Actinic Keratoses trials plan to enrol fewer than 100 people.
Median target enrolment is 44 among the 13 trials that report a genuine target (sentinel values excluded). 11 of those (84.6%) plan for fewer than 100 participants.
-
Actinic Keratoses research is mostly interventional.
13 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
13 total, page 1 of 1
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
Wright State University
NCT06428721
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
Wright State University
NCT03906253
Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
Psoriasis Treatment Center of Central New Jersey
NCT06745999
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
Biofrontera
NCT05662202
Photodynamic Therapy Incubation Times for Actinic Keratosis
Northwestern University
NCT03066843
Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face
Galderma R&D
NCT04085367
Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)
Biofrontera Bioscience
NCT04319159
Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational Video
University of California, Davis
NCT02062853
Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents
University of Arizona
NCT03279328
Daylight Photodynamic Therapy for Actinic Keratosis
University of California, San Francisco
NCT03322293
A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy
Goldman, Butterwick, Fitzpatrick and Groff
NCT02451579
A Photodynamic Therapy for Treatment of Actinic Keratoses
Northwestern University
NCT00558688
Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage
Sherrif Ibrahim
NCT07053852
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 3 | 2 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Actinic Keratoses records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Actinic Keratoses trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Actinic Keratoses page
13 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Actinic Keratoses trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Wright State University sponsors the most Actinic Keratoses trials on record, review their full trial history before evaluating a specific study. See Wright State University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Actinic Keratoses condition card totals 13 registered trials; most-linked intervention BF-200 ALA and red light LED lamp; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.